2023-03-30T16:58:22+08:00 weekly 1.0 https://fi.prisysbiotech.com/ 2024-11-08T23:32:07+08:00 weekly 0.9 https://fi.prisysbiotech.com/animal-welfare 2024-11-08T23:32:17+08:00 weekly 0.9 https://fi.prisysbiotech.com/metabolic-syndromes-research 2024-11-08T23:32:25+08:00 weekly 0.9 https://fi.prisysbiotech.com/respiratory-disease-research 2024-11-08T23:32:16+08:00 weekly 0.9 https://fi.prisysbiotech.com/ophthalmic-disease-research 2023-02-27T15:56:40+08:00 weekly 0.9 https://fi.prisysbiotech.com/co-develop 2024-11-08T23:32:03+08:00 weekly 0.9 https://fi.prisysbiotech.com/translational-research-center 2024-11-08T23:32:40+08:00 weekly 0.9 https://fi.prisysbiotech.com/inflammation-immunology-disorders 2024-11-08T23:32:37+08:00 weekly 0.9 https://fi.prisysbiotech.com/cns-disorders-behavior-analysis 2024-11-08T23:32:12+08:00 weekly 0.9 https://fi.prisysbiotech.com/hematological-disease-research 2026-08-08T12:49:13+08:00 weekly 0.9 https://fi.prisysbiotech.com/download 2024-09-29T14:45:25+08:00 weekly 0.9 https://fi.prisysbiotech.com/nephrology 2024-09-29T14:23:03+08:00 weekly 0.9 https://fi.prisysbiotech.com/fibrosis 2024-11-08T23:32:05+08:00 weekly 0.9 https://fi.prisysbiotech.com/about-us 2024-11-08T23:32:08+08:00 weekly 0.9 https://fi.prisysbiotech.com/contact-us 2023-04-01T12:12:50+08:00 weekly 0.9 https://fi.prisysbiotech.com/newslist-1 2024-11-08T23:32:08+08:00 weekly 0.9 https://fi.prisysbiotech.com/products 2023-04-01T11:43:11+08:00 weekly 0.9 https://fi.prisysbiotech.com/safety-evaluation/ 2023-04-01T11:43:11+08:00 weekly 0.9 https://fi.prisysbiotech.com/translation-research/ 2023-04-01T11:43:11+08:00 weekly 1.0 https://fi.prisysbiotech.com/nhp-pharmacology/ 2023-04-01T11:43:12+08:00 weekly 0.9 https://fi.prisysbiotech.com/biosafety-research/ 2023-04-01T11:43:16+08:00 weekly 0.9 https://fi.prisysbiotech.com/pk-pd-adme/ 2024-04-09T08:02:45+08:00 weekly 0.9 https://fi.prisysbiotech.com/clearpoint/ 2026-08-13T16:58:25+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html 2024-11-08T23:57:37+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/non-human-primate.html 2024-11-08T23:31:59+08:00 weekly 0.8 https://fi.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://fi.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html 2024-11-08T23:32:03+08:00 weekly 0.8 https://fi.prisysbiotech.com/pk-pd-adme/toxicokinetics.html 2024-11-08T23:32:14+08:00 weekly 0.8 https://fi.prisysbiotech.com/biosafety-research/biosafetyresearch.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://fi.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html 2024-11-08T23:32:12+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html 2024-11-08T23:32:08+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html 2024-11-08T23:32:06+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://fi.prisysbiotech.com/pk-pd-adme/adme.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://fi.prisysbiotech.com/safety-evaluation/toxicology.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html 2024-11-08T23:32:02+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html 2024-11-08T23:32:05+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://fi.prisysbiotech.com/translation-research/translational-studies.html 2024-11-08T23:32:02+08:00 weekly 0.8 https://fi.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html 2024-11-08T23:32:03+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html 2024-11-08T23:32:03+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html 2024-11-08T23:32:06+08:00 weekly 0.8 https://fi.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html 2024-11-08T23:32:04+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html 2024-11-08T23:32:07+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html 2024-11-08T23:32:05+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html 2024-11-08T23:31:58+08:00 weekly 0.8 https://fi.prisysbiotech.com/translation-research/nhpresources.html 2026-08-13T16:58:28+08:00 weekly 0.8 https://fi.prisysbiotech.com/safety-evaluation/immunotoxicity.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html 2024-11-08T23:32:02+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html 2024-11-08T23:32:04+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html 2024-11-08T23:32:18+08:00 weekly 0.8 https://fi.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html 2024-11-08T23:56:58+08:00 weekly 0.8 https://fi.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html 2024-11-08T23:32:12+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html 2024-11-08T23:57:06+08:00 weekly 0.8 https://fi.prisysbiotech.com/translation-research/clinical-imaging.html 2024-09-29T03:46:18+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html 2024-09-29T03:46:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html 2024-09-29T03:46:21+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html 2024-09-29T03:46:23+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html 2024-11-08T23:32:23+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html 2024-09-29T03:46:30+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html 2024-09-29T03:46:31+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html 2024-12-07T23:02:16+08:00 weekly 0.8 https://fi.prisysbiotech.com/clearpoint/nhp-neuroscience.html 2024-12-08T15:03:29+08:00 weekly 0.8 https://fi.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html 2025-04-01T18:13:46+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html 2025-04-01T18:47:30+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html 2025-07-20T16:57:27+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html 2025-07-20T16:57:56+08:00 weekly 0.8 https://fi.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html 2025-08-25T07:08:25+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html 2025-09-14T14:37:58+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html 2025-09-21T14:40:41+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html 2025-09-26T19:12:40+08:00 weekly 0.8 https://fi.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html 2025-10-05T01:19:29+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html 2025-12-25T19:48:23+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html 2026-01-29T22:06:27+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html 2026-05-01T23:41:06+08:00 weekly 0.8 https://fi.prisysbiotech.com/translation-research/dsa-guided-interventional-platform.html 2026-05-01T23:41:14+08:00 weekly 0.8 https://fi.prisysbiotech.com/pk-pd-adme/nhp-intrathecal-dosing-csf-sampling.html 2026-05-01T23:41:02+08:00 weekly 0.8 https://fi.prisysbiotech.com/pk-pd-adme/nhp-intracerebral-injection-icm-services.html 2026-05-01T23:41:21+08:00 weekly 0.8 https://fi.prisysbiotech.com/translation-research/biodistribution-imaging-service.html 2026-05-25T19:04:30+08:00 weekly 0.8 https://fi.prisysbiotech.com/pk-pd-adme/nhp-intracerebroventricular-icv-injection.html 2026-05-25T19:04:30+08:00 weekly 0.8 https://fi.prisysbiotech.com/nhp-pharmacology/nhp-focal-segmental-glomerulosclerosis-fsgs.html 2023-04-01T11:43:10+08:00 weekly 0.9 https://fi.prisysbiotech.com/newslist-714450-1 2023-04-01T11:43:11+08:00 weekly 0.9 https://fi.prisysbiotech.com/newslist-714451-1 2024-07-31T06:07:11+08:00 weekly 0.9 https://fi.prisysbiotech.com/newslist-819051-1 2026-05-01T23:28:24+08:00 weekly 0.9 https://fi.prisysbiotech.com/newslist-17854637898736640-1 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66141524.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/meetprisys-sot2023-66141525.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/prisys-sot2023-66141526.html 2026-09-01T20:56:57+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66141527.html 2026-09-01T20:56:45+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/gene-therapy-nhp-model-66141528.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66141529.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66141530.html 2026-09-01T20:56:46+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66141532.html 2026-09-01T20:56:56+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66141533.html 2026-09-01T20:56:46+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66143704.html 2026-09-01T20:56:43+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/gene-therapy-toxicology-66275560.html 2026-09-01T20:56:45+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67548886.html 2026-09-01T20:56:48+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67550812.html 2026-09-01T20:56:57+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67550813.html 2026-09-01T20:56:46+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67550814.html 2026-09-01T20:56:58+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67550815.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/world-parkinsons-disease-day-67570925.html 2026-09-01T20:56:47+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67579383.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67588423.html 2026-09-01T20:56:52+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68123386.html 2026-09-01T20:55:53+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68123387.html 2026-09-01T20:56:58+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68123520.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68123845.html 2026-09-01T20:56:01+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68330076.html 2026-09-01T20:56:11+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69076689.html 2026-09-01T20:56:09+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69077123.html 2026-09-01T20:56:10+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69077330.html 2026-09-01T20:56:10+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69077842.html 2026-09-01T20:56:10+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69078331.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69087003.html 2026-09-01T20:56:52+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309287.html 2026-09-01T20:56:23+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309304.html 2026-09-01T20:56:18+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309403.html 2026-09-01T20:56:49+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309404.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69665701.html 2026-07-21T03:10:01+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69667567.html 2026-09-01T20:56:50+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-71071671.html 2026-09-01T20:56:49+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-71071672.html 2026-09-01T20:57:05+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-71071677.html 2026-09-01T20:56:28+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-71071678.html 2026-09-01T20:56:59+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-71071679.html 2026-09-01T20:56:33+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/0-71071680.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72330055.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72330056.html 2026-09-01T20:56:57+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72330057.html 2026-09-01T20:56:55+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72330058.html 2026-09-01T20:57:01+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72330059.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72707633.html 2026-09-01T20:57:05+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73027635.html 2026-09-01T20:56:57+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73628972.html 2026-09-01T20:56:59+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73628973.html 2026-07-21T03:10:07+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74207719.html 2026-09-01T20:57:04+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74689746.html 2026-09-01T20:57:02+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74809735.html 2026-09-01T20:57:08+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75175214.html 2026-09-01T20:57:06+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75175218.html 2026-09-01T20:57:07+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76186049.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77075126.html 2026-09-01T20:57:16+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77743397.html 2024-11-08T23:32:18+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77743417.html 2026-09-01T20:57:29+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79202085.html 2026-09-01T20:59:29+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79202092.html 2026-09-01T20:59:28+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/nhp-asthma-model-79202105.html 2026-09-01T21:00:37+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79202108.html 2026-09-01T20:59:35+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79202421.html 2024-11-08T23:32:09+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79448256.html 2026-09-01T20:59:35+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79448257.html 2026-09-01T21:04:37+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79540408.html 2026-09-01T20:59:35+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79540410.html 2026-09-01T20:59:33+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/pk-strategies-of-pdc-79540412.html 2026-09-01T21:00:33+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79540414.html 2026-09-01T21:04:37+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79540416.html 2026-09-01T21:04:36+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79540417.html 2026-09-01T21:04:36+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79540418.html 2026-09-01T21:04:37+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79540420.html 2026-09-01T21:00:33+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79540421.html 2026-09-01T21:04:38+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79540422.html 2026-09-01T21:04:37+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79540423.html 2026-09-01T21:00:34+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79540424.html 2026-09-01T21:04:42+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79540425.html 2026-09-01T21:04:40+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79540426.html 2026-09-01T21:04:39+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79540427.html 2026-09-01T21:04:38+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79540428.html 2026-09-01T21:00:36+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79540429.html 2026-09-01T21:04:39+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79540430.html 2026-09-01T21:04:37+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79540431.html 2026-09-01T21:04:39+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79540432.html 2026-09-01T21:04:37+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79540433.html 2026-09-01T21:04:38+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79540434.html 2026-09-01T21:04:39+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79540435.html 2026-09-01T21:04:38+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79540436.html 2026-09-01T21:04:39+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79540437.html 2026-09-01T21:04:37+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79540438.html 2026-09-01T21:04:41+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79540439.html 2026-09-01T21:04:38+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79540440.html 2026-09-01T21:04:41+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79540441.html 2026-09-01T21:04:41+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79540443.html 2026-09-01T21:04:37+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79540444.html 2026-09-01T21:04:42+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79540445.html 2026-09-01T21:04:38+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79540446.html 2026-09-01T21:04:38+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79540447.html 2026-09-01T21:04:39+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79540448.html 2026-09-01T21:04:39+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79540449.html 2026-09-01T21:04:38+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/mrna-based-therapies-past-79540450.html 2026-09-01T21:04:39+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79540451.html 2026-09-01T21:04:38+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79540452.html 2026-09-01T21:04:41+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79540453.html 2026-09-01T21:04:43+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79540454.html 2026-09-01T21:04:40+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79540455.html 2026-09-01T21:04:41+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/mrna-based-therapies-present-79540456.html 2026-09-01T21:04:42+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79540457.html 2026-09-01T21:04:38+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79540458.html 2026-09-01T21:04:41+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79540459.html 2026-09-01T21:04:46+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79540460.html 2026-09-01T21:04:44+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/significance-principles-and-requirements-of-79540461.html 2026-09-01T21:04:42+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656497.html 2026-09-01T21:04:40+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81197906.html 2026-09-01T21:04:39+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/convection-enhanced-delivery-81197907.html 2026-09-01T21:04:42+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81197908.html 2026-09-01T21:10:48+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/china-experimental-monkey-industry-81197909.html 2026-09-01T21:04:39+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/animal-models-of-human-diseases-81197910.html 2026-09-01T21:04:39+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/human-disease-animal-models-81197912.html 2026-09-01T21:04:46+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81197913.html 2026-09-01T21:04:41+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81197914.html 2026-09-01T21:04:44+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81197915.html 2026-09-01T21:04:44+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81197918.html 2026-09-01T21:04:44+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81197919.html 2026-09-01T21:04:43+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81197920.html 2026-09-01T21:04:48+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/compartment-pk-model-81197921.html 2026-09-01T21:04:45+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82264247.html 2026-09-01T21:04:41+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82728272.html 2026-09-01T21:04:43+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82728273.html 2026-09-01T21:04:42+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82728274.html 2026-09-01T21:04:44+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82728275.html 2026-09-01T21:04:40+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82728277.html 2026-09-01T21:04:43+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82728285.html 2026-09-01T21:04:49+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82728292.html 2026-09-01T21:04:48+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82728297.html 2026-09-01T21:11:00+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82728300.html 2026-09-01T21:04:46+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83030176.html 2026-09-01T21:04:45+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83032385.html 2026-09-01T21:04:49+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83037363.html 2026-09-01T21:04:45+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-83977778.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-83977779.html 2026-09-01T21:04:45+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-83977781.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-83977792.html 2026-09-01T21:04:47+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-83977801.html 2026-09-01T21:04:43+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-83977812.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-83977813.html 2026-09-01T21:04:45+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-83977828.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-83977844.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17243118858298368.html 2026-09-01T21:04:56+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17243119183225856.html 2026-07-21T03:11:25+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17295186634253312.html 2026-09-01T21:04:43+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17295186679473152.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17295186686714880.html 2026-07-21T03:34:05+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/membranous-nephropathy-model-17295186714633216.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17295186752201728.html 2026-09-01T21:04:42+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/animal-models-for-womens-health-17295186783183872.html 2026-09-01T21:04:47+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17295186788557824.html 2026-09-01T21:04:44+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17295186794210304.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17295186811790336.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17295186956854272.html 2026-09-01T21:04:54+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17295186969830400.html 2026-09-01T21:04:41+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17295187048686592.html 2026-07-21T03:33:54+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17295187049882624.html 2026-09-01T21:04:59+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17295187069789184.html 2026-07-21T03:11:54+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17295187132572672.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17295219990455296.html 2026-07-21T03:34:01+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17298406325363712.html 2026-09-01T21:09:08+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17374208272344064.html 2026-09-01T21:09:12+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17374208282862592.html 2026-07-21T03:33:56+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17374208290825216.html 2026-07-21T03:34:00+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17374208299787264.html 2026-09-01T21:09:16+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17374208319661056.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17374208325116928.html 2026-07-21T03:33:53+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17374208354067456.html 2026-07-21T03:33:58+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/intracerebroventricular-icv-injection-17374208355902464.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17374208357884928.html 2026-07-21T03:34:06+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17374208426812416.html 2026-07-21T03:34:57+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17374208493233152.html 2026-07-21T03:33:55+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17374208561210368.html 2026-09-01T21:09:19+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17450825226281984.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17450825260934144.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17450825266390016.html 2026-07-21T03:33:55+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17450825333187584.html 2026-09-01T21:10:57+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17450825334383616.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17450825380652032.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17450825417188352.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17450825421186048.html 2026-09-01T21:03:32+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17450825531352064.html 2026-07-21T03:34:00+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/key-considerations-for-dosing-volume-17450825547490304.html 2026-07-21T03:18:26+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17450866515616768.html 2026-07-21T03:33:50+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17450866749531136.html 2025-08-25T07:08:25+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17501190759621632.html 2025-08-25T07:08:33+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17501190814426112.html 2026-09-01T21:10:55+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17501190859858944.html 2025-08-25T07:08:37+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/nhp-copd-model-17501190875915264.html 2026-09-01T21:10:58+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17501190988473344.html 2025-08-25T07:08:40+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17501191017096192.html 2025-09-14T14:37:56+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/brain-targeted-drug-delivery-17529939657565184.html 2025-09-14T14:37:58+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/the-importance-of-administration-volume-17529939674440704.html 2025-09-14T14:38:05+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17529939674964992.html 2026-09-01T21:10:59+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17529939713188864.html 2026-07-21T03:34:43+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17529939735880704.html 2025-09-14T14:37:59+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17529939827631104.html 2025-09-14T14:38:29+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17529939847029760.html 2026-09-01T21:11:06+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17539887638045696.html 2025-10-05T01:19:50+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17558882316870656.html 2026-09-01T21:11:02+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17634172588450816.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17634172649169920.html 2026-07-21T03:34:13+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17634172685820928.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17634172717573120.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/rfp-template-for-nhp-studies-17634172770804736.html 2026-09-01T21:10:54+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17634172790662144.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17634172915753984.html 2026-09-01T21:11:11+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17634172983796736.html 2026-07-21T03:34:04+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/nhp-renal-biopsy-17634173045400576.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17634173181355008.html 2026-09-01T21:10:53+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17634173295535104.html 2025-12-25T19:48:16+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674643074114560.html 2026-07-21T03:34:53+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674643102196736.html 2025-12-25T19:48:11+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17674643118498816.html 2025-12-25T19:48:19+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674643133424640.html 2025-12-25T19:48:10+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674643166471168.html 2026-09-01T21:11:01+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674643166798848.html 2025-12-25T19:48:28+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674643182167040.html 2025-12-25T19:48:19+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674643193766912.html 2026-07-21T03:34:01+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674643297231872.html 2026-01-29T22:06:32+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724313643410432.html 2026-01-29T22:06:34+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724313674998784.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724313780823040.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724313801548800.html 2026-01-29T22:06:41+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724314068247552.html 2026-01-29T22:06:44+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724314086777856.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724314425549824.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724335494947840.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724335518344192.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724335524373504.html 2026-05-01T23:28:45+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/ipf-drug-development-nhp-ct-imaging-pft-17854637880058880.html 2026-05-01T23:28:44+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/large-animal-radiolabeling-and-in-vivo-imaging-17854637972939776.html 2026-05-01T23:28:42+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/ai-markerless-nhp-3d-behavior-analysis-system-17854638016046080.html 2026-05-01T23:28:40+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/evaluating-dmpk-properties-17854638051107840.html 2026-05-01T23:28:42+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/drug-development-reliance-on-nhp-models-17854638140351488.html 2026-05-01T23:28:39+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/nhp-cns-biodistribution-studies-intrathecal-17854638168990720.html 2026-05-01T23:28:45+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/pet-ct-biodistribution-in-nhp-models-for-cns-17854638170072064.html 2026-05-01T23:28:47+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/dopamine-transporter-pet-imaging-in-nhp-models-17854638260823040.html 2026-05-01T23:28:47+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/mri-guided-cns-delivery-in-nhp-models-17854638479188992.html 2026-05-01T23:37:22+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/in-vivo-immune-cell-tracking-17854645610701824.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-antibody-safety-17854646754567168.html 2026-05-01T23:38:43+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/prisys-supports-ind-approval-of-ux-gip001-17854646900614144.html 2026-05-01T23:38:01+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/nonlinear-pharmacokinetics-nhp-pkpd-17854647234536448.html 2026-05-01T23:41:16+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/non-glp-pharmacology-data-integrity-17854649582396416.html 2026-05-01T23:41:16+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/nonclinical-pharmacokinetics-strategy-17854649835906048.html 2026-05-01T23:41:10+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/translational-pk-pd-framework-cynomolgus-17854650067641344.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/nhp-models-translational-drug-development-17888363402683392.html 2026-07-21T05:33:37+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/pk-data-as-translational-biomarker-17888363469399040.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/non-human-primate-models-of-pulmonary-fibrosis-17888363473052672.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/pk-data-as-pharmacodynamic-biomarker-17888363688174592.html 2026-07-21T05:33:44+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/on-demand-webinar-mri-ced-nhp-17888364193866752.html 2026-07-21T05:33:31+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-17939758388536320.html 2026-07-21T03:18:36+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/clinical-pathology-interpretation-dogs-nhp-17939760495092736.html 2026-07-21T05:33:38+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/what-is-molecular-imaging-drug-development-17939761834664960.html 2026-07-21T05:33:47+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/nhp-heart-failure-model-17939765013881856.html 2026-07-21T05:33:37+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/molecular-imaging-biomarkers-advancing-transl-17939774401356800.html 2026-07-21T05:33:40+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/nhp-radionuclide-biodistribution-17939775853782016.html 2026-07-21T05:33:36+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/nonlinear-pharmacokinetics-explained-17939778442028032.html 2026-07-21T05:33:44+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/dsa-cta-cardiovascular-drug-safety-imaging-17939797132338176.html 2026-07-21T05:33:38+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/nhp-molecular-imaging-translational-pet-studie-17939799252182016.html 2026-07-21T03:33:55+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/ai-nhp-behavioral-analysis-17968121666741248.html 2026-07-21T03:33:57+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/nhp-models-of-maternal-high-fat-diet-and-child-17968121797927936.html 2026-07-21T03:33:58+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/pain-mechanisms-the-uvb-sunburn-model-17968121801483264.html 2026-07-21T03:33:55+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/nhp-behavioratlas-3d-behavioral-tracking-17968122020258816.html 2026-07-24T18:53:36+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/markerless-3d-nhp-behavior-analysis-17973272961344512.html 2026-07-24T18:53:38+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/nhp-aav-gene-therapy-model-mri-guided-ced-17973273049162752.html 2026-07-24T18:55:33+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/why-positive-control-drugs-matter-in-autoimmun-17973273438430208.html 2026-07-24T18:53:52+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/baseline-ada-screening-washed-out-monkeys-17973273475474432.html 2026-08-23T06:44:37+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/webinar-nhp-behavioratlas-17973273734849536.html 2026-07-24T18:53:59+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/when-to-introduce-nhp-studies-autoimmune-drug-17973274205234176.html 2026-07-24T18:53:55+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/nhp-ibd-model-chronic-enterocolitis-17973274820502528.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/behavior-in-rhesus-17983366048097280.html 2026-09-10T15:42:20+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/midd-and-nhp-efficacy-models-in-drug-17983366066971648.html 2026-08-05T18:59:26+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/pk-biomarkers-preclinical-drug-development-17990268830049280.html 2026-09-01T21:10:51+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/webinar-recap-digital-behavioral-phenotyping-17993013272945664.html 2026-09-01T21:10:57+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/molecular-imaging-in-nhp-model-webinar-18003097284453376.html 2026-09-01T21:10:57+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/pbpk-vs-compartmental-models-drug-development-18003097488548864.html 2026-09-01T21:10:54+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/3d-ai-tracking-nhp-behavior-18015032361296896.html 2026-08-23T08:07:17+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/pet-biodistribution-nhp-studies-18015111338222592.html 2026-09-01T21:11:13+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/quantitative-pet-target-engagement-in-nhps-for-18021128264262656.html 2026-09-01T11:33:12+08:00 weekly 0.8 https://fi.prisysbiotech.com/news/animal-models-succeed-or-fail-in-drug-dev-18028053819548672.html